ENDRA Life Sciences Faces Delisting Concerns
Ticker: NDRA · Form: 8-K · Filed: May 30, 2025 · CIK: 1681682
| Field | Detail |
|---|---|
| Company | Endra Life Sciences INC. (NDRA) |
| Form Type | 8-K |
| Filed Date | May 30, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
TL;DR
ENDRA might get delisted, check their listing status ASAP.
AI Summary
ENDRA Life Sciences Inc. filed an 8-K on May 30, 2025, reporting a notice of delisting or failure to meet continued listing standards. The company's principal executive offices are located at 3600 Green Court, Suite 350, Ann Arbor, MI 48105. The filing date for this report is May 30, 2025, with the earliest event reported on May 27, 2025.
Why It Matters
This filing indicates potential issues with ENDRA Life Sciences' ability to remain listed on its current exchange, which could significantly impact its stock liquidity and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's continued operation as a publicly traded entity.
Key Players & Entities
- ENDRA Life Sciences Inc. (company) — Registrant
- May 27, 2025 (date) — Earliest event reported
- May 30, 2025 (date) — Filing date
- 3600 Green Court, Suite 350, Ann Arbor, MI 48105 (address) — Principal executive offices
FAQ
What specific listing rule or standard has ENDRA Life Sciences Inc. failed to meet?
The filing does not specify the exact rule or standard that ENDRA Life Sciences Inc. has failed to meet, only that it is a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard'.
What is the date of the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on May 27, 2025.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted to the SEC on May 30, 2025.
Where are ENDRA Life Sciences Inc.'s principal executive offices located?
ENDRA Life Sciences Inc.'s principal executive offices are located at 3600 Green Court, Suite 350, Ann Arbor, MI 48105.
What is the Commission File Number for ENDRA Life Sciences Inc.?
The Commission File Number for ENDRA Life Sciences Inc. is 001-37969.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 30, 2025 regarding ENDRA Life Sciences Inc. (NDRA).